Literature DB >> 23322178

[CD30-positive anaplastic large cell T-cell lymphoma developing during immunosuppressive therapy of pityriasis rubra pilaris with ustekinumab].

D Humme1, M Beyer, H-J Röwert-Huber, W Sterry, S Philipp.   

Abstract

The development of malignancies during therapy with biologics has been discussed controversially. A patient with extensive pityriasis rubra pilaris failed to respond to standard therapeutic approaches. While receiving immunomodulatory therapy, lastly with ustekinumab, the patient developed a CD30(+) anaplastic large cell lymphoma.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23322178     DOI： 10.1007/s00105-012-2526-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  17 in total

1.  Exacerbation of undiagnosed mycosis fungoides during treatment with etanercept.

Authors:  Philippe Lafaille; Danielle Bouffard; Nathalie Provost
Journal:  Arch Dermatol       Date:  2009-01

2.  Cutaneous gamma/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis.

Authors:  Lianne Koens; Nancy J Senff; Maarten H Vermeer; H Karel Ronday; Rein Willemze; Patty M Jansen
Journal:  Acta Derm Venereol       Date:  2009-11       Impact factor: 4.437

3.  Hepatosplenic T-cell lymphoma in patients receiving TNF-α inhibitor therapy: expanding the groups at risk.

Authors:  Deepak Parakkal; Humberto Sifuentes; Rumi Semer; Eli Daniel Ehrenpreis
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-11       Impact factor: 2.566

4.  Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis.

Authors:  Eva Baecklund; Anastasia Iliadou; Johan Askling; Anders Ekbom; Carin Backlin; Fredrik Granath; Anca Irinel Catrina; Richard Rosenquist; Nils Feltelius; Christer Sundström; Lars Klareskog
Journal:  Arthritis Rheum       Date:  2006-03

Review 5.  Biologic therapy in psoriasis: perspectives on associated risks and patient management.

Authors:  Kim A Papp; Joel Dekoven; Laurie Parsons; Syed Pirzada; Michael Robern; Lynne Robertson; Jerry K L Tan
Journal:  J Cutan Med Surg       Date:  2012 May-Jun       Impact factor: 2.092

6.  Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): results from analyses of infections and malignancy from pooled phase II and III clinical trials.

Authors:  Kenneth B Gordon; Kim A Papp; Richard G Langley; Vincent Ho; Alexa B Kimball; Cynthia Guzzo; Newman Yeilding; Philippe O Szapary; Steven Fakharzadeh; Shu Li; Ming-Chun Hsu; Kristian Reich
Journal:  J Am Acad Dermatol       Date:  2011-10-05       Impact factor: 11.527

Review 7.  Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Authors:  Tim Bongartz; Alex J Sutton; Michael J Sweeting; Iain Buchan; Eric L Matteson; Victor Montori
Journal:  JAMA       Date:  2006-05-17       Impact factor: 56.272

Review 8.  Formulary review of 2 new biologic agents: tocilizumab for rheumatoid arthritis and ustekinumab for plaque psoriasis.

Authors:  Jeremy A Schafer; Nicole K Kjesbo; Patrick P Gleason
Journal:  J Manag Care Pharm       Date:  2010 Jul-Aug

Review 9.  CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab.

Authors:  E Mahé; V Descamps; M Grossin; S Fraitag; B Crickx
Journal:  Br J Dermatol       Date:  2003-07       Impact factor: 9.302

10.  Successful treatment of pityriasis rubra pilaris (type 1) under combination of infliximab and methotrexate.

Authors:  Dietrich Barth; Wolfgang Harth; Regina Treudler; Jan C Simon
Journal:  J Dtsch Dermatol Ges       Date:  2009-12       Impact factor: 5.584
View more
  3 in total

Review 1.  Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn's Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature.

Authors:  Fabiënne G M Smeets; Paulien R Liedorp; Marjolein van der Poel; Razvan L Miclea; Ad A M Masclee; Marieke Pierik
Journal:  J Crohns Colitis       Date:  2019-10-28       Impact factor: 9.071

2.  Acute Promyelocytic Leukemia in a Patient With Chronic Continuous Type of Crohn's Disease.

Authors:  Shiori Kinoshita; Satoshi Tanida; Akimi Kawai; Kazuhide Shiraga; Tomoyuki Nakamura; Kana Oiwa; Tomotaka Suzuki; Asahi Ito; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Shinsuke Iida
Journal:  J Clin Med Res       Date:  2022-03-25

3.  A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis.

Authors:  Emmanouil Charakopoulos; Ioannis Spyrou; Nora-Athina Viniou; Nefeli Giannakopoulou; Sevastianos Hatzidavid; Panagiotis Theodorou Diamantopoulos
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.